Consumers probably aren’t the only ones complaining about the rising cost of prescription drugs—not after the U.S. Food and Drug Administration (FDA) just socked drug study sponsors with hefty price […]
The U.S. Food and Drug Administration (FDA) just issued a call to industry and other interested parties to weigh in on an important draft guidance, “E8(R1) General Considerations for Clinical Studies.”
If you have the pleasure of knowing me in the professional world, or perhaps sitting through one of my lectures, you’re all too familiar with what I have to say […]
With Australian specialty pharmaceutical company Race Oncology’s announcement last week that the first patient had been treated with the “lost” drug Bisantrene in a clinical trial for relapsed/refractory acute myeloid […]
There’s no “silver bullet" or “holy grail” when it comes to juggling complex, multi-center clinical trials, says Samantha Sharpe, CCRP, Program Manager, Nationwide Children’s Hospital: Abigail Wexner Research Institute. “There’s […]